Eli Lilly and Company /
Verve Therapeutics, Inc.
Eli Lilly and Company agrees to buy Verve Therapeutics, Inc.
Source for the buyer and target: Verve Therapeutics, Inc.
For the buyer and target.
“As previously disclosed in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on June 17, 2025, Verve Therapeutics, Inc., a Delaware corporation (“Verve” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 16, 2025, by and among the Company, Eli Lilly and Company, an Indiana corporation (“Parent”), and Ridgeway Acquisition Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Purchaser”).”
Published 25 Jul 2025
Open the sourceWhat happened
Eli Lilly and Company agreed to acquire Verve Therapeutics, Inc., according to a filing dated July 25, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Eli Lilly and Company agrees to buy Verve Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“Eli Lilly and Company agrees to buy Verve Therapeutics, Inc. Eli Lilly and Company agreed to acquire Verve Therapeutics, Inc., according to a filing dated July 25, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly